IN-33
Hymenoptera stings, 4–57—4–58
assessment of, 4–58
follow-up for, 4–59
patient education for, 4–59
signs of, 4–58
symptoms of, 4–58
treatment for, 4–58
Hyoscyamine
for prostatitis, 3–82
for urinary incontinence, 4–90
Hyperbaric chamber
for high altitude cerebral edema, 6–40
for high altitude pulmonary edema, 6–41,
6–42
portable, 8–36
equipment for use of, 8–36—8–37
indications for, 8–36
precautions with, 8–37
treatment with, 8–37
Hyperbaric oxygen recompression therapy
for carbon monoxide poisoning, 6–11
for decompression sickness, 6–5, 6–36
for pulmonary over inflation syndrome, 6–8
Hypercapnia. See Carbon dioxide poisoning
Hyperglycemia, 4–29
Hyperhidrosis, 5–7, 5–8
Hyperkeratosis, 4–67
in corns and calluses, 5–5
Hyperlite transport chamber, 8–36
for decompression sickness, 6–36
for high altitude cerebral edema, 6–40
for high altitude pulmonary edema, 6–42
Hypersensitivity pneumonitis, 4–18
Hypertension
in eclampsia, 3–105
headache in, 3–55
in preeclampsia/eclampsia, 3–104
with sleep apnea, 4–25
Hypertensive emergency
assessment of, 4–5
in congestive heart failure, 4–4
defined, 4–5
follow-up, 4–6
patient education for, 4–5
signs of, 4–5
symptoms of, 4–5
treatment of, 4–5
Hyperthermia, 6–37, 6–39
Hyperthyroidism, 4–31—4–32
in diabetes mellitus, 4–28
diagnosis of, 4–32—4–33
differential diagnosis of, 4–33
fever with, 3–31
in mania, 3–16
symptoms of, 4–32
treatment of, 4–33
Hypertonic saline-colloid combinations, 7–15t
Hyphema
differential diagnosis of, 3–27
treatment of, 3–28
Hypocalcemic tetany, 5–101
Hypochromasia, hemoglobin variations in, 8–56
Hypoglycemia
alleviating or aggravating factors of, 4–30
assessment of, 4–31
causes of, 4–30
differential diagnosis of, 6–44
follow-up, 4–31
patient education for, 4–31
signs of, 4–30
symptoms of, 4–30
treatment of, 4–31
Hypoglycemic agents, 4–29
Hypotension, 7–12
Hypotensive states, 4–27
Hypothermia, 6–46t
assessment of, 6–44
with chemical burns, 7–18
classification of level of, 6–45t
definition of, 6–43
differential diagnosis of, 6–37, 6–39
follow-up for, 6–44
patient education for, 6–44
symptoms and signs of, 6–43
in trauma patients, 7–3
treatment for, 6–44
Hypothyroidism, 4–32
apnea with, 4–26
in depression, 3–16
in diabetes mellitus, 4–28
diagnosis of, 4–33
differential diagnosis of, 4–33
fatigue with, 3–30t
symptoms of, 4–32
treatment of, 4–33
Hypoventilation, voluntary, 6–12
Hypovolemia, syncope with, 3–118
Hypovolemic shock
assessment of, 7–12—7–13
cause of, 7–11—7–12
hemorrhage control in, 7–13
signs of, 7–12
symptoms of, 7–12
treatment for, 7–13—7–14
Hypoxemia
in apnea, 4–26
fatigue with, 3–30t
Hypoxia
in aerospace medicine, 6–31
assessment of, 6–9, 6–31
in carbon dioxide poisoning, 6–12
differential diagnosis of, 6–11, 6–12, 6–36
in diving operations, 6–8—6–9
follow-up for, 6–9, 6–32
memory loss with, 3–86
patient education for, 6–9, 6–32
signs of, 6–9, 6–31
symptoms of, 6–9, 6–31
treatment for, 6–9, 6–31
Hytrin (terazosin)